NATICK, Mass., April 17, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will host an investor event on May 8, 2014 to provide an update on company Cardiac Rhythm Management and Electrophysiology initiatives as well as developments and technologies in connection with its attendance at the 2014 Annual Heart Rhythm Society Scientific Session in San Francisco, CA. The event, which will include a question and answer session, is scheduled to begin at 5:00 p.m. PT and adjourn at approximately 6:30 p.m. PT.
Participants will include Mike Mahoney, president and chief executive officer, Dan Brennan, executive vice president and chief financial officer, Joe Fitzgerald, executive vice president and president, Rhythm Management, Kenneth Stein, M.D., senior vice president and chief medical officer, Rhythm Management. Martin Burke, D.O., Director, Heart Rhythm Center, University of Chicago Medical Center, will also present.
A live webcast of the event will be available to interested parties via the Boston Scientific website. Webcast registration is available on the Investor Relations section of the website at www.bostonscientific.com/investors. Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.
A replay will be archived and available at www.bostonscientific.com/investors beginning approximately one hour following the completion of the event.
About Boston Scientific Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.
Media: Denise Kaigler 508-650-8330 (office) Corporate Affairs & Communications Boston Scientific Corporation firstname.lastname@example.org
Investors: Susie Lisa, CFA 508-652-5345 (office) Investor Relations Boston Scientific Corporation email@example.com
SOURCE Boston Scientific Corporation